Silk Road Medical to Present at the Stifel 2020 Virtual Healthcare Conference

Rhea-AI Summary

Silk Road Medical (Nasdaq: SILK) announced its participation in the Stifel 2020 Virtual Healthcare Conference on November 17, 2020, at 3:20 p.m. Eastern Time. The company aims to reduce stroke risks through its TransCarotid Artery Revascularization (TCAR) procedure, which addresses carotid artery blockages. Interested individuals can access the live or archived webcast of the presentation through the company's website. This event highlights Silk Road Medical's commitment to improving patient outcomes and enhancing clinical practices.

SUNNYVALE, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming Stifel 2020 Virtual Healthcare Conference.

Silk Road Medical’s management is scheduled to present on Tuesday, November 17, 2020 at 3:20 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/.

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company’s flagship procedure, TransCarotid Artery Revascularization (TCAR), is clinically proven to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Caroline Paul
Gilmartin Group
investors@silkroadmed.com

FAQ

When will Silk Road Medical present at the Stifel 2020 Virtual Healthcare Conference?

Silk Road Medical will present on November 17, 2020, at 3:20 p.m. Eastern Time.

What is the focus of Silk Road Medical?

Silk Road Medical focuses on reducing the risk of stroke through innovative medical devices.

How can I access the Silk Road Medical conference presentation?

You can access the live and archived presentation on the Investors section of Silk Road Medical's website.

What is the flagship procedure of Silk Road Medical?

The flagship procedure is the TransCarotid Artery Revascularization (TCAR), proven to treat carotid artery blockages.